MYCN and ganglioneuroblastoma: Based on the INRGSS, very low-risk tumors encompass stage L1/L2 maturing ganglioneuroma or intermixed ganglioneuroblastoma, stage L1 tumors with non-amplified MYCN, and stage MS in children younger than 18 months of age with no 11q aberration.